Survival outcomes of primary versus interval visceral-peritoneal debulking (VPD) surgery in patients with stage IIIC-IV ovarian cancer and complete resection: A cohort study

被引:0
|
作者
Tozzi, R. [1 ]
Majd, H. Soleymani [2 ]
Campanile, R. Garruto [2 ]
Desgro, M. [2 ]
Morotti, M. [2 ]
Casarin, J. [2 ]
机构
[1] Oxford Univ Hosp, Oxford, England
[2] Oxford Univ Hosp NHS Trust, Oxford, England
关键词
D O I
10.1016/j.ygyno.2018.04.261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
251
引用
收藏
页码:112 / 113
页数:3
相关论文
共 50 条
  • [31] Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients
    Zhang, Jie
    Liu, Ning
    Zhang, Aihong
    Bao, Xiangxiang
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (09) : 1808 - 1816
  • [32] Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity
    Tozzi, Roberto
    Ferrari, Federico
    Nieuwstad, Joost
    Campanile, Riccardo Garruto
    Majd, Hooman Soleymani
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (02)
  • [33] NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY DEBULKING SURGERY IN FIGO STAGE III AND IV EPITHELIAL OVARIAN, TUBAL OR PERITONEAL CANCER
    Tzanis, A.
    Iavazzo, C. R.
    Hadjivasilis, A.
    Tsouvali, H.
    Antoniou, G.
    Antoniou, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A296 - A296
  • [34] Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer - a retrospective cohort study
    Maricic, Slobodan
    Mandic, Aljosa
    Dejanovic, Ninoslav
    Kladar, Nebojsa
    Popovic, Marina
    Ivkovic-Kapicl, Tatjana
    Gutic, Bojana
    Kokanov, Dunja
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1193 - 1199
  • [35] Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
    Rutten, Marianne J.
    Sonke, Gabe S.
    Westermann, Anneke M.
    van Driel, Willemien J.
    Trum, Johannes W.
    Kenter, Gemma G.
    Buist, Marrije R.
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2015, 2015
  • [36] Racial disparities in women with stage IIIC and IV epithelial ovarian cancer receiving neoadjuvant chemotherapy versus primary debulking surgery: A National Cancer Database study
    Whitmore, G. T.
    Ramzan, A. A.
    Sheeder, J.
    Guntupalli, S. R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 121 - 122
  • [37] Primary versus interval debulking surgery for advanced ovarian cancer: differences in surgical complications, perioperative outcomes and survival
    Teixeira, Natalia
    Sanchez, Raquel Munoz
    Descamps, Eva Magret
    Carrera, Silvia Martorell
    Sans, Claudia Pellicer
    Bigardi, Sofia
    Rubi, Alba Farres
    Moreno, Cristina Soler
    Negre, Ramon Rovira
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A398 - A398
  • [38] Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical complexity and morbidity
    Tozzi, R.
    Majd, H. Soleymani
    Ferrari, F.
    Campanile, R. Garruto
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 81 - 81
  • [39] Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
    Sioulas, Vasileios D.
    Schiavone, Maria B.
    Kadouri, David
    Zivanovic, Oliver
    Roche, Kara Long
    O'Cearbhaill, Roisin
    Abu-Rustum, Nadeem R.
    Levine, Douglas A.
    Sonoda, Yukio
    Gardner, Ginger J.
    Leitao, Mario M., Jr.
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (01) : 15 - 20
  • [40] CYTOREDUCTIVE SURGERY IN STAGE IIIC AND IV EPITHELIAL OVARIAN CANCER, A PROSPECTIVE COHORT STUDY
    Mitsopoulos, V.
    Innamaa, A.
    Lippiatt, J.
    Plevris, N.
    Biliatis, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A496 - A496